JP5933419B2 - Diterpene compound, whitening agent and method for producing diterpene compound - Google Patents

Description

  The present invention relates to a novel diterpene compound, a whitening agent containing the novel diterpene compound as an active ingredient, and a method for producing the diterpene compound.

  The color of the skin depends on the melanin pigment present in the skin. Stains, freckles, and pigmentation after sunburn are thought to occur as a result of deposition of excessive melanin pigments on the epidermis by ultraviolet rays or the like. When tyrosinase acts on tyrosine in melanocytes, it changes to dopa, dopaquinone, dopachrome, and indolequinone, and finally oxidizes and polymerizes to form a brownish melanin. For this reason, as a component that suppresses the generation of stains and buckwheat itself in the body, it is considered to inhibit the melanin production process, or to lighten or bleach the produced melanin. As compounds that inhibit tyrosinase activity, sulfur compounds such as kojic acid, ellagic acid, and glutathione and hydroquinone preparations are known. In addition, compounds having 1-ene-3-ol as a partial structure, such as nerolidol, isophytol, geranyl linalool (Patent Document 1) or manur as a starting material are synthesized as those having a melanin production inhibitory action. 13-oxo-14,15-dinol-8- (17) -labdane (Patent Document 2) and the like are used as melanin production inhibitors.

  On the other hand, there is a report that a whitening component is contained in the stevia extract (Patent Document 3). Stevia is a perennial plant belonging to the genus Stevia from South America. It contains steviol glycosides with a sweetness of 300 times that of sucrose as a sweetening ingredient. It is a plant that has been used. The steviol glycoside contains components such as stevioside, rebaudioside A, rebaudioside C, and zulcoside A. In patent document 3, the tyrosinase activity inhibition rate of the water extract part of stevia leaf (dried product), 50% ethanol extract, and ethanol extract was evaluated, and the tyrosinase activity inhibition rate was about 50 to 58%, respectively. It is disclosed that it is excellent in safety and whitening action.

  There is also a melanin production inhibitor containing stevia extract (Patent Document 4). When the melanin production inhibition rate of the extract obtained by extracting the stevia leaf and stem pulverized product with 50% ethanol solution was evaluated, it was about 20%, and this inhibition effect was about 10% of melanin production inhibition rate. It is superior to kojic acid.

  Furthermore, there is also a whitening cosmetic product comprising Sophoraflavanone G, Centaureidine, and ascorbic acid (Patent Document 5). Centauridine can be extracted from stevia, yarrow, yacon, etc., and 1.6 g of amorphous containing centerureidine is obtained from 5 kg of stevia rhizomes. The above-mentioned whitening cosmetic has the effect of increasing the melanin production inhibitory action of ascorbic acids by using centaureidine and sophoraflavanone G, preventing and improving pigment abnormalities associated with inflammation, and after the inflammation has subsided as a secondary effect The skin surface condition can also be improved significantly.

Japanese Patent No. 3236130 Japanese Patent No. 4235602 JP-A-9-77636 JP 11-335233 A Japanese Patent No. 4471722

  However, the effect of inhibiting melanin synthesis by the above-mentioned kojic acid, ellagic acid, etc. is extremely low. When the content is increased in order to obtain a sufficient effect, there may be a limit of blending due to solubility or the like. Moreover, the component described in patent document 1 and patent document 2 is a synthetic product. Whitening ingredients and the like act on human skin, and it is preferable to use ingredients derived from natural products and to be excellent in safety.

  Then, when attention was paid to edible stevia to ensure safety, as described in Patent Document 3 and Patent Document 4, the tyrosinase activity inhibitory action in the ethanol extract of dried stevia leaves is known. Here, when using it for the external preparation applied directly to skin etc., it is preferable to use a pure component which does not contain other impurities, and this can also remove allergic components and the like. However, Patent Document 3 calculates the tyrosinase activity inhibition rate using the lyophilized product of the ethanol extract as it is, and no compound is specified. Further, Patent Document 4 does not teach a specific compound. Therefore, development of a new compound having an excellent whitening effect is desired.

  Further, Patent Document 5 is characterized by the effect produced by the composite component by combining centauridine extracted from stevia, sophoraflavanone G extracted from legumes, and melanin production inhibitory action by ascorbic acid. In addition, components such as centaureidine alone do not have an inhibitory effect on melanin production. Therefore, it is desired to develop a novel compound having a whitening effect alone.

  Further, it is desired that the whitening agent is used in various fields as a basic cosmetic and a make-up cosmetic and can be stably supplied. Therefore, development of an inexpensive manufacturing method is desired.

  In view of the above-mentioned present situation, an object of the present invention is to provide a novel compound excellent in safety and whitening effect.

  Moreover, an object of this invention is to provide the whitening agent which uses the novel compound which is excellent in the whitening effect as an active ingredient.

  Furthermore, an object of this invention is to provide the manufacturing method of the novel compound which is excellent in the whitening effect.

  The present inventors have examined Stevia plants in detail, and that the fermented liquid obtained by fermenting Stevia plants with yeast contains components different from Stevia plants, and that the Stevia yeast fermented liquid has extremely high melanin production. A diterpene compound exhibiting an inhibitory effect was included, and the compound was found to have low cytotoxicity and can be used as a whitening agent, thereby completing the present invention.

  That is, the present invention provides a diterpene compound represented by the following formula (VIII) or a medically acceptable salt thereof.

  The present invention also provides a whitening agent comprising a diterpene compound represented by the above formula (VIII) or a medically acceptable salt thereof as an active ingredient.

  The present invention is also characterized in that a stevia plant or a stevia plant extract is fermented with yeast to prepare a stevia yeast fermentation product, and the diterpene compound represented by the above formula (VIII) is recovered from the stevia yeast fermentation product. A method for producing the diterpene compound is provided.

  According to the present invention, a novel diterpene compound represented by the above formula (VIII) is provided. The said compound is excellent in the melanin production inhibitory effect, and can be used as a whitening agent.

In Example 1, it is a figure explaining the isolation | separation process and yield at the time of manufacturing the compound shown by Formula (VIII).

  The first of the present invention is a diterpene compound represented by the following formula (VIII) or a medically acceptable salt thereof.

  In the present invention, “medically acceptable salt” refers to a salt form that is a compound of the present invention that is pharmacologically acceptable and substantially non-toxic to an administered subject. The pharmaceutically acceptable salts of the diterpene compounds include conventional stoichiometric acid addition salts or base addition salts formed from suitable non-toxic organic or inorganic acids or inorganic bases. Suitable inorganic acids are, for example, halogen acids such as hydrochloric acid, sulfuric acid or phosphoric acid. Suitable organic acids are, for example, carboxylic acids, phosphonic acids or sulfonic acids, such as acetic acid, propionic acid, glycolic acid, lactic acid, hydroxybutyric acid, malic acid, maleic acid, malonic acid, salicylic acid, fumaric acid, 琥珀Acids, adipic acid, tartaric acid, citric acid, glutaric acid, 2- or 3-glycerophosphoric acid, and other mineral acids well known to those skilled in the art. The salt is prepared by contacting the free base form with a sufficient amount of the desired acid to produce the salt in the conventional manner. Compounds containing acidic substituents can also form salts with inorganic or organic bases. Examples of suitable bases for forming salts include, but are not limited to, inorganic bases such as alkali or alkaline earth metal (eg, sodium, potassium, lithium, calcium, or magnesium) hydroxides, and ammonium water. There are those derived from oxides (eg, quaternary ammonium hydroxides such as tetramethylammonium hydroxide). Also contemplated are salts formed with pharmaceutically acceptable amines such as ammonia, alkylamines, hydroxyalkylamines, N-methylglucamine, benzylamine, piperidine, and pyrrolidine. Certain compounds are acidic, such as compounds having a carboxyl group or a phenolic hydroxyl group. Phenol salts can be made by heating acidic compounds with any of the bases described above by procedures well known to those skilled in the art.

  Although the said compound can be manufactured by chemical synthesis, it can be extracted, for example from the yeast fermented material of a stevia plant. Instead of stevia plants, stevia plant extracts obtained by extracting steviol glycosides and the like from stevia plants in advance with a solvent such as water may be used. That is, in the second aspect of the present invention, a stevia plant or a stevia plant extract is fermented with yeast to prepare a stevia yeast fermentation product, and the diterpene compound represented by the above formula (VIII) is recovered from the stevia yeast fermentation product. A process for producing a diterpene compound.

  Yeast is a microorganism that discharges alcohol and carbon dioxide from sugar, and this action is used to produce alcoholic beverages such as sake, beer, wine, fermented foods such as miso, soy sauce, cheese, kimchi, and bread. . In the present invention, when a yeast fermentation solution obtained by fermenting a stevia plant with yeast is analyzed in detail, the diterpene compound represented by the above formula (VIII), which is a component that does not exist in the stevia plant and has an excellent whitening effect, is obtained. Was found to be produced. As yeast, it is preferable to use Saccharomyces.

  The stevia plant (scientific name: Stevia rebaudiana) used in the present invention is a perennial plant belonging to the genus Stevia which is native to South America. Terpenoid glycosides such as stevioside and rebaudioside A extracted from stevia plants are used as sweeteners and are currently cultivated in Asia such as Japan, China and Korea. In the present invention, in particular, Stevia Rebaudiana Bertoni and its related plants can be preferably used. Stevia plants that can be used include Stevia plant stems, leaves, whole plants before buds, mature plant roots and flowers.

  The “stevia plant extract” to be fermented is an extract obtained by extracting a specific component from a stevia plant with water or another solvent. Stevia plants include steviol glycosides that can be used as sweeteners, and include crude steviol glycosides obtained by extracting steviol glycosides from stevia plants with water at high concentrations. In the present invention, such a crude steviol glycoside can be used as a stevia plant extract. In the present invention, even when yeast is added to such a stevia plant extract and fermented, the diterpene compound can be recovered from the fermented product.

  As the stevia plant, a plant harvested at an appropriate time can be used as it is, or a plant that has been dried after harvesting can be used. The dried product is excellent in storage stability and is suitable. Fermentation is started when a dried stevia plant is cut into a predetermined size, pulverized or otherwise chopped or crushed, and yeast is added and stirred. It is preferable that a stevia plant selects and uses a leaf part and a stem part.

  In the case of using a dried product as a raw material, it can be carried out by adding water and yeast to a dried stevia powder that has been chopped or pulverized, stirring the mixture, and allowing to stand. The amount of water to be added is sufficient as long as it is necessary for fermentation, and an amount sufficient to wet the whole is sufficient. Stevia plants before fermentation have sweetness due to terpenoid glycosides, but the sweetness disappears as fermentation progresses. In the present invention, the disappearance of sweetness is taken as a measure of the end of fermentation. Such disappearance of sweetness is 2-3 weeks at room temperature. In addition to adding yeast at the beginning of fermentation, it may be added during the fermentation.

  In the present invention, the yeast is added to the stevia plant for fermentation, and the dried stevia plant is crushed and boiled and extracted, or the soaking solution obtained by immersing in warm water, from the stevia plant A predetermined fraction extracted with water or other solvent may be used as a stevia plant extract, and the yeast may be added to this and fermented. Again, the end of fermentation can be confirmed by the disappearance of sweetness.

  Next, the stevia yeast fermented product is dried. Stevia yeast fermented product contains yeast, but the activity of the yeast can be stopped by drying it. Drying is preferably performed at a temperature of 5 to 35 ° C. by air drying, natural drying, or the like. Decomposition, alteration, etc. of the compound contained in the stevia yeast fermented product can be avoided.

Stevia yeast fermented product contains the diterpene compound of the present invention.
As the extraction solvent for the diterpene compound, either a polar solvent or a nonpolar solvent can be used, or a mixture of these can be used. As the extraction solvent, water, alcohols that may have 1 to 12 carbon atoms such as methanol, ethanol, propanol, butanol, polyhydric alcohols such as ethylene glycol, propylene glycol, butylene glycol, Ketones such as acetone and methyl ethyl ketone, esters such as methyl acetate and ethyl acetate, ethers such as tetrahydrofuran and diethyl ether, polyethers such as polyethylene glycol, halogenated carbons such as dichloromethane, chloroform and carbon tetrachloride, hexane , Hydrocarbons such as cyclohexane and petroleum ether, aromatic hydrocarbons such as benzene and toluene, pyridines, supercritical carbon dioxide, fats and oils, waxes and other oils. These may be used alone or in combination.
In the present invention, it is preferable to use alcohol. As alcohol, C1-C5 monohydric alcohol is suitable. Among these, ethanol is particularly preferable. The alcohol may be a hydrous alcohol containing water. In the case of using a hydrous alcohol, the alcohol concentration is preferably 30 to 99 (v / v)%, more preferably 50 to 90 (v / v)%. Extraction with alcohol or hydrous alcohol is performed by adding 0.1 to 100 parts by mass, preferably 1 to 50 parts by mass of solvent to 1 part by mass (dry weight) of the above stevia yeast fermented product, at a temperature of 5 to 35 ° C. Soaking for 3 to 30 days is preferred.

  After immersion in alcohol or hydrous alcohol, the solid and the extract are separated by centrifugation, filtration, or the like. The diterpene compound of the present invention is contained in the extract. For example, the solvent of the extract can be removed, and liquid-liquid distribution, column chromatography, liquid chromatography, gel filtration, activated carbon treatment, precision distillation, etc. can be performed alone or in combination. These can be appropriately selected depending on the type of extraction solvent used and the like. Since the diterpene compound is a lipophilic component, the diterpene compound can be efficiently isolated by extracting using a lipophilic solvent in which the diterpene compound can be dissolved and purifying the extract.

  Examples of lipophilic solvents in which such diterpene compounds can be dissolved include halogenated carbons such as dichloromethane, chloroform and carbon tetrachloride, hydrocarbons such as hexane, cyclohexane and petroleum ether, and aromatic hydrocarbons such as benzene and toluene. There is kind. In the present invention, chloroform can be preferably used. This is because solvent extraction can be applied to a large volume and is excellent in the recovery rate of the diterpene compound. The lipophilic solvent extract can be used as a lipophilic fraction after removing the solvent. However, the lipophilic solvent extract may be washed with water and then the lipophilic solvent may be removed to obtain a lipophilic fraction.

  In place of the lipophilic solvent, 100 parts by mass of the lipophilic solvent, water, alcohols having 1 to 3 carbon atoms such as methanol and ethanol, polyhydric alcohols such as ethylene glycol, and ketones such as acetone and methyl ethyl ketone. , A lipophilic solvent-hydrophilic solvent mixture in which esters such as methyl acetate and ethyl acetate, ethers such as tetrahydrofuran and diethyl ether, mixtures thereof, and other hydrophilic solvents are added in the range of 60 to 100 parts by volume. It can also be extracted. Lipophilic solvent and hydrophilic solvent may be separated into two layers by standing after mixing. By combining such lipophilic solvent and hydrophilic solvent, the target product is transferred to the lipophilic solvent layer. At the same time, acetic acid and other water-soluble components contained in the stevia yeast fermented product can be transferred to the hydrophilic solvent layer. Such lipophilic solvents include chloroform, and hydrophilic solvents include water and methanol. A mixture of chloroform and water mixed at 9: 3.5 to 5 (volume ratio) is separated into a chloroform layer and an aqueous layer when left after extraction, so that the target component is recovered in the chloroform layer and hydrophilic. The solvent can be transferred to the aqueous layer and can be easily separated from the water-soluble component.

  The novel diterpene compound of the present invention can be recovered from the lipophilic fraction by a known method. For purification, for example, the diterpene compound is separated from other components based on the difference in polarity by silica gel column chromatography or reverse phase column, or separated by molecular weight, or a plurality of solvents having different solubility are used. Purification by differences in solubility can also be performed. Since the diterpene compound of the present invention is excellent in the melanin production inhibitory effect, the presence or absence of impurities is confirmed by TLC or the like for each fraction, and simultaneously the melanin production inhibitory effect is evaluated, and the target component is purified using this as an index. Can do.

  The third of the present invention is a whitening agent containing a diterpene compound represented by the above formula (VIII) as an active ingredient. The diterpene compound which concerns on 1st invention of this invention is excellent in the melanin production inhibitory effect as shown in the Example mentioned later, and its cytotoxicity is low. For this reason, the said compound can be used as a melanin production inhibitor and a whitening agent. The whitening agent of the present invention may be administered orally including oral administration, sublingual administration, etc. in addition to transdermal administration such as application.

  Examples of external dosage forms for whitening agents include ointments, liquids, sprays, plasters, fats and oils, and powders. The whitening agent may be a basic cosmetic such as lotion, milky lotion, cream or pack, a makeup base such as a makeup base, sunscreen, foundation or fun, or a detergent such as shampoo or face wash. The blending amount of the diterpene compound with respect to these whitening agents can be appropriately selected depending on the base material, but is 0.000001 to 20% by mass, preferably 0.00001 to 10% by mass, more preferably 0.0001 to 5% by mass. Especially preferably, it is 0.0001-3 mass%.

  As other components constituting the whitening agent, components blended in the whitening agent such as normal cosmetics, quasi-drugs, and pharmaceuticals can be blended according to the dosage form and the like. Such ingredients include preservatives such as methyl paraoxybenzoate, propyl paraoxybenzoate, phenoxyethanol, thymol, antibiotics such as sodium bisulfite, ascorbic acid, tocopherol, dibutylhydroxytoluene, sodium edetate hydrate, and benzotriazole. Surfactant such as oxidizing agent, glyceryl monostearate, sorbitan monostearate, polyoxyethylene hydrogenated castor oil 60, polysorbate 60, citric acid hydrate, sodium citrate hydrate, yeast, diisopropanolamine, acetic acid, Examples include pH adjusters such as sodium acetate hydrate, humectants, thickeners, inorganic fillers, colorants, fragrances, ultraviolet absorbers, cell activators, various skin nutritional ingredients, and the like. Other base materials and the like can be appropriately added to prepare any of external solutions, external solids, sprays, ointments, creams, gels, patches, and others.

EXAMPLES Next, although an Example is given and this invention is demonstrated concretely, these Examples do not restrict | limit this invention at all.
Example 1

(1) Preparation of Stevia Fermented Yeast Stevia Plant Stevia (Stevia rebaudiana) produced in Hokkaido, Japan was dried and crushed to about 1 cm or less. Fermentation started when 45 g of yeast (Saccharomyces) and 4,500 g of water were added to 2,000 g of ground stevia plant and stirred under conditions of a temperature of 25 to 35 ° C. This was allowed to stand and ferment at a temperature of 25 to 35 ° C. for 14 days. The sweetness disappeared from the fermented product, and this was regarded as the end of fermentation. The fermented product was dried at a temperature of 25 to 35 ° C. for 10 days to stop yeast fermentation.

(2) Extraction of hydrous ethanol The total amount of the dried fermented product was added to 10 mass times 28.5 (v / v)% ethanol and allowed to infiltrate at room temperature for several days with gentle stirring. After infiltration, it was filtered with a size of about 140 mesh. The obtained filtrate was concentrated under reduced pressure (60 mmHg) at about 60 ° C., adsorbed on a Diaion HP20 column, and then eluted with an 85.5% aqueous ethanol solution to obtain an aqueous ethanol extract.

(3) Chloroform extraction To the extract (60 g) obtained by distilling off the solvent of the aqueous ethanol extract, 1000 mL of chloroform was added, followed by extraction at a temperature of 23 to 28 ° C (room temperature). The residue was removed by filtration, the chloroform layer was separated, and the solvent was distilled off to obtain a chloroform extract (28.8 g).

(4) Isolation of target product The chloroform extract (28.8 g) obtained in (3) above was separated into 7 fractions by silica gel column chromatography shown in the following separation condition (1).
Separation conditions (1):
Column: Inner diameter 7cm, Height 22cm
Filling: Silica gel (manufactured by KANTO CHEMICAL, Silica Gel 60N (spherical, neutral), particle size 63-210 μm), 320 g,
Elution solvent: Chloroform: methanol = 100: 1 → 50: 1 → 30: 1 → 15: 1 → 7: 1 → 5: 1 → 0: 1 200 mL each.
Fractionated product: Fractions were fractionated into 7 fractions a to g for each elution solvent. The yield of each fraction is shown in FIG.

The fraction d (3.5 g) was separated into 8 fractions by silica gel column chromatography shown in the following separation condition (2).
Separation condition (2):
Column: inner diameter 5.2cm, height 20cm
Filling: Silica gel (manufactured by KANTO CHEMICAL, Silica Gel 60N (spherical, neutral), particle size 63-210 μm), 160 g,
Elution solvent: Chloroform: methanol = 100: 1 → 50: 1 → 20: 1 → 10: 1 → 5: 1 → 2: 1 → 0: 1 150 mL each.
Fractionated product: Fractions were fractionated into 8 fractions d-1 to d-8 for each elution solvent. The yield of each fraction is shown in FIG.

Next, the d-4 fraction was separated into 13 fractions by silica gel column chromatography shown in the following separation condition (3).
Separation condition (3):
Column: inner diameter 4.2cm, height 20cm
Filling: Silica gel (manufactured by KANTO CHEMICAL, Silica Gel 60N (spherical, neutral), particle size 63-210 μm), 90 g,
Elution solvent: n-hexane: acetone = 7: 1 → 3: 1 → 1: 1 → 1: 2 → 0: 1 As an eluent, 700 mL of each solvent was sequentially passed through the column, and 70 mL was fractionated. .
Fraction: The yield of each fraction is shown in FIG. Each fraction was subjected to _{TLC (MERCK Silica Gel 60 F 254} ). After developing with a solvent of n-hexane: acetone = 1: 1, 50% sulfuric acid was sprayed and heated at 110 ° C. for detection. The d-4-7 fraction was detected as a single spot. Removal of the solvent in this fraction gave a white powder. This compound was designated as compound VIII.

(5) Structure determination About the white powder, ¹ H-NMR and ¹³ C-NMR were measured. The results are shown in Table 1. ^From the signal patterns of ¹ H-NMR and ¹³ C-NMR, it is presumed that Sturpentine A, A ring, and B ring, which have 20 carbon atoms and have already been isolated from Stevia, have the same structure, but after C ring The structure of was estimated to be different. Then, when the correlation of HMQC and HMBC was examined in detail, the HMBC correlation shown in Table 1 was recognized, and it was finally determined to be a diterpene compound represented by the following formula (VIII). The basic skeleton and position number of the compound are shown in the lower part of Table 1.

(Example 2)
About the compound obtained in Example 1, according to the following measuring method, according to the calculation method of the melanin production amount per cell number and the melanin production rate with respect to a control | contrast, B16 melanoma cell viable count was measured, and the melanin production amount per solution was measured. Thus, the amount of melanin production (ng / 10 ⁴ cells) per living cell was calculated. Moreover, the melanin density | concentration by the compound of Formula (VIII) with respect to the melanin production amount (ng / 10 < ⁴ > cells) per control living cell was computed. The results are shown in Table 2. The concentration of the compound was 100 μM, and 1000 μM kojic acid was similarly treated for comparison.

(Measuring method)
The calculation method of the melanin production amount per cell number and the melanin production rate with respect to the control was as follows.
The medium of B16 mouse melanoma cells cultured overnight in a 6-well plate was removed, and 10% -FBS-DMEM medium (for sample lysis) containing theophylline (final concentration 10 mM) and a sample of the target concentration in each well. 2 mL of DMSO was added in a final concentration of 0.1%).
After culturing at 37 ° C. in the presence of 5% CO ₂ for 72 hours, the medium was removed, and the cells were rinsed twice with a pH 7.4 isotonic phosphate buffer (PBS). Each well was treated with trypsin by adding 200 μl of a 0.25% trypsin-EDTA solution, and 1 ml of the medium was added to collect the entire amount in a 15 ml centrifuge tube. The cell solution is centrifuged at 1000 rpm for 5 minutes, 2 ml of PBS is added to the cells from which the supernatant has been removed and resuspended. 200 μl of this is transferred to a microtube, and the cell counter (Millipore Corporation, Sceptor (registered trademark)) Was used to count the number of cells. The remaining cell solution was centrifuged again under the same conditions, the supernatant was removed, 1 ml of 1M NaOH was added, and the mixture was treated in an 80 ° C. water bath for 1 hour. The absorbance of the concentration of the cell lysate was measured at a wavelength of 475 nm using Immuno Mini NJ-2300 (manufactured by Cosmo Bio Corporation), and the amount of melanin produced per number of cells was calculated. For the calibration curve, synthetic melanin (manufactured by Sigma-Aldrich Corporation) melted in 1M NaOH was used. The data was expressed as a melanin production rate and a viable cell number rate per number of cells where the value of the control (1 mM theophylline-added medium applied) group was 100%, and expressed as an average value n standard deviation of n = 3, respectively. For statistical analysis, analysis of variance (ANOVA) and multiple comparison test (Dunnet method) were used.

  The novel diterpene compound of the present invention has a lower melanin production rate than kojic acid known as a melanin production inhibitor, can exhibit an excellent whitening action, has low toxicity, is excellent in safety, and is useful.

Claims (3)

The diterpene compound shown by following formula (VIII), or those medically acceptable salts.

A whitening agent comprising a diterpene compound represented by the following formula (VIII) or a medically acceptable salt thereof as an active ingredient.

Stevia plant or Stevia plant extract is yeast fermented to prepare stevia yeast fermented product,
A method for producing the diterpene compound, comprising collecting the diterpene compound represented by the following formula (VIII) from the fermented stevia yeast.

Images